'Serostim' http://www.humangrowthhormones.biz/serostim.xml/ 2008-11-20T20:33:58+01:00 text/html http://www.humangrowthhormones.biz/human-growth-hormone/serostim.xml/#business-wire----merck-serono-and-flamel-to-collaborate-on-an-extended-release-formulation-for-therapeutic-proteins December 20, 2007 -- Flamel's Medusa([R]) technology designed to allow less frequent administration of therapeutic proteins and peptides LYON, France -- Flamel... text/html http://www.humangrowthhormones.biz/human-growth-hormone/serostim.xml/#business-wire----to-date,-only-one-recognisably-biosimilar-drug,-human-growth-hormone,-has-appeared-in-developed-markets:-will-a-significant-biosimilar-market-develop? September 13, 2006 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c42003) has announced the addition of Espicom Business Analysis's... text/html http://www.humangrowthhormones.biz/human-growth-hormone/serostim.xml/#business-wire----rodman-&-renshaw-3rd-annual-global-healthcare-conference-2006-presenter-profiles May 12, 2006 -- MONTE CARLO, Monaco -- Rodman & Renshaw 3rd Annual Global Healthcare Conference 2006 takes place May 15-16 in Monte Carlo. For in-depth... text/html http://www.humangrowthhormones.biz/human-growth-hormone/serostim.xml/#worldwide-biotech----serono's-gonal-f-approved-in-japan-for-hypogonadism March 1, 2006 -- Serono (virt-x: SEO and NYSE: SRA) has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Gonal-f(R) 75 IU and... text/html http://www.humangrowthhormones.biz/human-growth-hormone/serostim.xml/#afp----serono-posts-106-million-dollar-2005-loss,-after-us-fine February 6, 2006 -- GENEVA (AFP) — The Swiss-based biotechnology and pharmaceuticals company Serono announced a 106.1-million-dollar (89.6-million-euro) net loss... text/html http://www.humangrowthhormones.biz/human-growth-hormone/serostim.xml/#medical-marketing-and-media----serono-pleads-guilty-to-marketing-scam February 1, 2006 -- SERONO LABORATORIES formally pleaded guilty in December to criminal charges involving schemes to promote, market and sell its AIDS-wasting drug... text/html http://www.humangrowthhormones.biz/human-growth-hormone/serostim.xml/#m2-presswire----curran-recovers-$922,000-for-maryland-medicaid-program. January 11, 2006 -- M2 PRESSWIRE-11 January 2006-MARYLAND ATTORNEY GENERAL: Curran recovers $922,000 for Maryland Medicaid program(C)1994-2006 M2 COMMUNICATIONS LTD... text/html http://www.humangrowthhormones.biz/human-growth-hormone/serostim.xml/#u.s.-newswire----serono-labs-pleads-guilty-to-the-illegal-marketing-of-aids-drug December 16, 2005 -- BOSTON, Dec. 16 /U.S. Newswire/ -- The U.S. subsidiary, SERONOLABORATORIES, INC., of Swiss Corporation SERONO, S.A., pleaded guiltyand was sentenced... text/html http://www.humangrowthhormones.biz/human-growth-hormone/serostim.xml/#afp----swiss-serono-pleads-guilty-in-aids-drug-marketing-scheme December 15, 2005 -- WASHINGTON (AFP) — Serono Laboratories Inc., the US subsidiary of Swiss pharmaceutical group Serono SA, pleaded guilty and was sentenced on US... text/html http://www.humangrowthhormones.biz/human-growth-hormone/serostim.xml/#medical-marketing-and-media----news:-update November 1, 2005 -- The FDA will hold public hearings on communication of drug safety information Dec. 7-8 in Washington, D.C. The agency will look at the effectiveness...